Growth Metrics

RxSight (RXST) Change in Receivables (2020 - 2026)

RxSight filings provide 6 years of Change in Receivables readings, the most recent being -$788000.0 for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 116.83% to -$788000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.7 million, a 167.89% decrease, with the full-year FY2025 number at -$6.7 million, down 167.89% from a year prior.
  • Change in Receivables hit -$788000.0 in Q4 2025 for RxSight, up from -$3.9 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $5.0 million in Q4 2023 to a low of -$3.9 million in Q3 2025.
  • Median Change in Receivables over the past 5 years was $1.1 million (2022), compared with a mean of $1.0 million.
  • Biggest five-year swings in Change in Receivables: soared 566.45% in 2024 and later crashed 1120.94% in 2025.
  • RxSight's Change in Receivables stood at $504000.0 in 2021, then skyrocketed by 283.93% to $1.9 million in 2022, then soared by 160.31% to $5.0 million in 2023, then decreased by 7.05% to $4.7 million in 2024, then crashed by 116.83% to -$788000.0 in 2025.
  • The last three reported values for Change in Receivables were -$788000.0 (Q4 2025), -$3.9 million (Q3 2025), and -$2.9 million (Q2 2025) per Business Quant data.